The Westminster lensArchive · Written questions · 503 tabled · 489 answered

Written questions by Perteghella.

Every parliamentary written question tabled by Manuela Perteghella this session, with the full answer and department. See how every department answers, or back to the MP page.

Department:All (503)Department of Health and Social Care (125)Department for Education (75)Department for Environment, Food and Rural Affairs (50)Ministry of Housing, Communities and Local Government (43)Department for Work and Pensions (38)Treasury (27)Foreign, Commonwealth and Development Office (26)Home Office (22)Department for Transport (19)Department for Science, Innovation and Technology (18)Ministry of Defence (16)Ministry of Justice (13)

Showing 4160 of 125 · Department of Health and Social Care

← PreviousPage 3 of 7Next →
16 Jan 2026·Department of Health and Social Care·Answered
Asked

What steps his Department is taking to ensure that continuous NHS service is recognised across (a) primary, (b) secondary and (c) community care settings for the purposes of (i) redundancy pay and (ii) employment protections.

Reply

The Department understands the significance of recognising continuous service across different parts of the health system. Sections 12 and 16 of the National Health Service terms and conditions of service (Agenda for Change) handbook establish redundancy entitlements and employment protections for staff directly employed on Agenda for Change contracts in England, as well as employees whose contracts refer to Section 16. These arrangements are collectively agreed with NHS trade unions.Employers such as general practices within primary care operate as independent entities rather than NHS employers. Nevertheless, employers retain discretion to consider non-NHS service when calculating redundancy benefits, where this experience is relevant to NHS employment. NHS policy indicates that it may be reasonable, but is not obligatory, for employers to consider this previous service in the redundancy. These decisions should be mutually agreed upon by both the employer and employee at the point of joining or returning to the NHS.Collectively, sections 12 and 16 ensure that staff retain redundancy protections when moving between NHS organisations, while affording employers the flexibility to acknowledge any relevant external experience, which supports fairness and consistency in redundancy outcomes across the NHS. NHS Employers provides guidance to support the consistent implementation of NHS redundancy provisions across all settings. Ultimately, NHS organisations are responsible for administering the nationally agreed redundancy terms.

16 Jan 2026·Department of Health and Social Care·Answered
Asked

What assessment he has made of the potential impact of fragmented recognition of service across different NHS sectors on long-serving NHS staff during redundancy processes.

Reply

The Department has not made an assessment of how fragmented recognition of service across different National Health Service sectors might affect long-serving NHS staff who face redundancy.Redundancy entitlements for NHS staff are determined by Section 16 of the NHS Terms and Conditions of Service (Agenda for Change) handbook, which covers employees directly employed on Agenda for Change contracts in England and those whose contracts refer to Section 16. These arrangements are collectively agreed with NHS trade unions and also specify how previous NHS employment is defined and counted when determining redundancy pay.Local employers are responsible for confirming entitlement to a redundancy payment, and these terms will be stipulated in an employee’s contract of employment. The redundancy rules as described above apply to those employed by NHS employers in England as listed in Annex 1 of the Agenda for Change handbook. Employers must determine an individual’s redundancy entitlement in accordance with Section 16 as nationally agreed between employers and NHS trade unions. If someone has worked outside the NHS but in a role relevant to NHS employment, NHS policy recommends that it would be reasonable, but not a requirement, for employers to consider this service in any redundancy calculation. This consideration should be agreed between the employer and employee either upon joining or returning to the NHS.

16 Jan 2026·Department of Health and Social Care·Answered
Asked

What steps he is taking to prevent experienced women with non-linear NHS careers from being disproportionately excluded from leadership development opportunities during periods of (a) workforce restructuring and (b) redundancy.

Reply

NHS England actively promotes inclusion and accessibility in its formal leadership development programmes, including for experienced women with non-linear careers. Diversity data is monitored at every stage of selection to identify and address any risk of disproportionate exclusion.National leadership development programmes offered by NHS England are designed to assess potential, skills, and experience rather than continuous career progression. Entry routes are flexible and inclusive, enabling participation from colleagues working part-time, returning from career breaks, or with varied professional backgrounds.A wider programme of work is underway to support and develop National Health Service leaders including the commitment to establish a College of Executive and Clinical Leadership for the NHS. The college will provide access to development for all levels of managers and leaders, including those with non-linear career paths, to support them to succeed and progress in their NHS careers.

16 Jan 2026·Department of Health and Social Care·Answered
Asked

What assessment his Department has made of the potential impact of redundancy on access to levy-funded leadership development for experienced NHS staff; and whether he plans to introduce mitigations to prevent the loss of training opportunities following involuntary redundancy.

Reply

No assessment has been made of the potential impact of redundancy on access to levy-funded development for experienced National Health Service staff.The Department for Education issues guidance for all apprentices who are at risk of redundancy, which is available on their website. This sets out the terms for supporting apprentices at risk of redundancy and for continuing to fund their apprenticeships following redundancy.To further bolster training opportunities for experienced NHS staff, NHS England is expanding some national leadership and development offers, increasing flexible and mid-career offers, and widening access based on skills and potential rather than linear progression. Additional targeted outreach and career support are being used in places to encourage participation from experienced staff, including during periods of organisational change.

6 Jan 2026·Department of Health and Social Care·Answered
Asked

What steps he plans to take to increase (a) capacity of and (b) access to radiotherapy cancer treatment in (i) England and (ii) Stratford-upon-Avon.

Reply

Radiotherapy is crucial to cancer treatment, and it remains a key priority for the Government to reduce radiotherapy waiting times and provide high quality treatment for all patients, including those in Stratford-upon-Avon. This is why the Government has invested £70 million of central funding on 28 new LINAC radiotherapy machines across the country to replace older, less efficient radiotherapy machines. This crucial investment will boost treatment efficiency and productivity, freeing up capacity and reduce waiting times for patients. These new machines are currently being rolled out and have already started treating cancer patients across the country.The Coventry and Warwickshire NHS Trust received £2.3 million to replace ageing radiotherapy equipment from an underspend in the National Health Service’s capital settlement for 2024/25.

6 Jan 2026·Department of Health and Social Care·Answered
Asked

Whether the National Cancer Plan will address access to, and capacity for, radiotherapy services for cancer patients.

Reply

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as how we will reduce waiting times for diagnosis and treatment.Improving access to all treatment services, including radiotherapy, remains a key priority for the Government. Our commitment to radiotherapy services is demonstrated by our £70 million investment in new LINAC radiotherapy machines to replace older, less efficient equipment. This crucial investment will boost treatment efficiency and productivity, freeing up capacity and reduce waiting times for patients. These new machines are currently being rolled out and have already started treating cancer patients across the country.

6 Jan 2026·Department of Health and Social Care·Answered
Asked

Whether the National Cancer Plan will address (a) access to and (b) capacity for radiotherapy services for cancer patients.

Reply

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as how we will reduce waiting times for diagnosis and treatment.Improving access to all treatment services, including radiotherapy, remains a key priority for the Government. Our commitment to radiotherapy services is demonstrated by our £70 million investment in new LINAC radiotherapy machines to replace older, less efficient equipment. This crucial investment will boost treatment efficiency and productivity, freeing up capacity and reduce waiting times for patients. These new machines are currently being rolled out and have already started treating cancer patients across the country.

16 Dec 2025·Department of Health and Social Care·Answered
Asked

What alternative NHS roles are available to people who have completed accredited Physician Associate training but are unable to secure employment as Physician Associates.

Reply

Recruitment and retention of physician assistant, still legally known as physician associate (PA), roles into the National Health Service is the responsibility of individual employers in primary and secondary care as part of local and regional workforce planning. Decisions on alternative roles for newly qualified PAs rests with local employers, who will need to consider their workforce model, staffing numbers and skill mix as part of a wider workforce strategy aligned to service priorities.Nationally, NHS England continues to work closely with partners, supported by colleagues in the regions, to consider what guidance and support can be provided to employers to implement the Leng Review recommendations related to the employment of PAs.

9 Dec 2025·Department of Health and Social Care·Answered
Asked

What steps he is taking to (a) monitor and (b) regulate the cost of COVID-19 vaccinations offered by private providers for people who are not eligible for a free vaccination.

Reply

The availability of COVID-19 vaccines to supply the private market and the price charged for private COVID-19 vaccination is a matter for the companies concerned, not for the Government. All those eligible to receive a COVID-19 vaccination this autumn through the National Health Service, in line with advice by the independent expert Joint Committee on Vaccination and Immunisation, are encouraged to take up this offer. The national programme launched on 1 October 2025 and runs until 31 January 2026.

9 Dec 2025·Department of Health and Social Care·Answered
Asked

What assessment his Department has made of the potential impact of restricting eligibility for free covid-19 vaccinations on (a) infection rates, (b) hospital admissions and (c) mortality during winter 2025–26 on adults aged between 65 and 74 years old.

Reply

The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.The JCVI is an independent expert committee which reviews the latest data on COVID-19 risks, vaccine safety, and effectiveness and advises the Government on eligibility for vaccination and immunisation programmes. The JCVI’s advice on COVID-19 vaccination for autumn 2025 is based on published analysis which considers the health impacts of vaccination against COVID-19 in various groups. This is available at the following link:https://www.sciencedirect.com/science/article/pii/S0264410X25002452The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.The Government has accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:adults aged 75 years old and over;residents in care homes for older adults; andindividuals aged six months old and over who are immunosuppressed, as defined in the ‘immunosuppression’ sections of tables 3 or 4 in the COVID-19 chapter of the UK Health Security Agency Green Book.The JCVI keeps all vaccination programmes under review.The UK Health Security Agency (UKHSA) continues to monitor COVID-19 through a variety of indicators and surveillance systems. Data are analysed and published by the UKHSA in weekly official statistics in the National Influenza and COVID-19 Surveillance Report. For the autumn 2025 campaign, this is available at the following link:https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2025-to-2026-season

9 Dec 2025·Department of Health and Social Care·Answered
Asked

What assessment his Department has made of the potential impact of restricting eligibility for free covid-19 vaccinations on (a) infection rates, (b) hospital admissions and (c) levels of mortality during winter 2025–26.

Reply

The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.The JCVI is an independent expert committee which reviews the latest data on COVID-19 risks, vaccine safety, and effectiveness and advises the Government on eligibility for vaccination and immunisation programmes. The JCVI’s advice on COVID-19 vaccination for autumn 2025 is based on published analysis which considers the health impacts of vaccination against COVID-19 in various groups. This is available at the following link:https://www.sciencedirect.com/science/article/pii/S0264410X25002452The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.The Government has accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:adults aged 75 years old and over;residents in care homes for older adults; andindividuals aged six months old and over who are immunosuppressed, as defined in the ‘immunosuppression’ sections of tables 3 or 4 in the COVID-19 chapter of the UK Health Security Agency Green Book.The JCVI keeps all vaccination programmes under review.The UK Health Security Agency (UKHSA) continues to monitor COVID-19 through a variety of indicators and surveillance systems. Data are analysed and published by the UKHSA in weekly official statistics in the National Influenza and COVID-19 Surveillance Report. For the autumn 2025 campaign, this is available at the following link:https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2025-to-2026-season

3 Dec 2025·Department of Health and Social Care·Answered
Asked

What recent assessment he has made of the potential merits of improving systems to identify men with (a) BRCA1 and (b) BRCA2 gene variations who may be eligible for prostate cancer screening.

Reply

The National Inherited Cancer Predisposition Register (NICPR), launched 1 July 2025, captures data on all individuals with a likely pathogenic/pathogenic variant in a cancer susceptibility gene in England. This world-first national dataset of individuals at increased cancer risk provides significant opportunities for improved clinical care, audit, and research.The NICPR is part of the National Disease Registration Service and is a new initiative for NHS England. In view of the UK National Screening Committee’s (UK NSC) draft recommendations on screening men for prostate cancer, NHS England is working closely with colleagues in regional clinical genetics services to ensure that accurate data is gathered and can be applied effectively to inform future work.My Rt Hon. Friend, the Secretary of State for Health and Social Care will consider the final recommendation of the UK NSC on screening for prostate cancer when it is received. He will make a decision on implementation, including any changes to BRCA testing eligibility, at that point.It is anticipated that the final recommendation will be provided in early 2026 after the conclusion of a 12 week consultation which opened on 28 November 2025. This seeks views on an evidence review and a draft recommendation to:- offer a targeted national prostate cancer screening programme to men with confirmed BRCA1/2 gene variants every two years, from 45 years old to 61 years old;- not recommend population screening;- not recommend targeted screening of black men;- not recommend targeted screening of men with family history; and- collaborate with the Transform trial team to answer outstanding questions on screening effectiveness for black men and men with a family history as soon as the trial data becomes available, and to await the results of the study to develop and trial a more accurate test than the prostate specific antigen test alone, to improve the balance of benefit and harm of screening.

3 Dec 2025·Department of Health and Social Care·Answered
Asked

What steps his Department is taking to utilise electronic health records indicating familial genetic predisposition to improve risk identification for men at increased risk of prostate cancer.

Reply

The NHS Retrospective Genetic Testing Programme is using electronic health records to identify people who have had a cancer diagnosis, between 2008 and 2018, making them eligible for inherited breast and ovarian cancer genetic testing on R208/R207 panels in line with the criteria set out in the National Genomic Test Directory, but who have not received testing. This will identify more people and their family members who have cancer susceptibility genes, including BRCA1/2 variants, enabling them to access relevant National Health Service screening and care pathways as appropriate.My Rt Hon. Friend, the Secretary of State for Health and Social Care will consider the final recommendation of the UK National Screening Committee (UK NSC) on screening for prostate cancer when it is received. He will make a decision on implementation, including any changes to the identification of men at risk of prostate cancer at that point.It is anticipated that the final recommendation will be provided in early 2026 after the conclusion of a 12 week consultation which opened on 28 November 2025. This seeks views on an evidence review and a draft recommendation to:- offer a targeted national prostate cancer screening programme to men with confirmed BRCA1/2 gene variants every two years, from 45 years old to 61 years old;- not recommend population screening;- not recommend targeted screening of black men;- not recommend targeted screening of men with family history; and- collaborate with the Transform trial team to answer outstanding questions on screening effectiveness for black men and men with a family history as soon as the trial data becomes available, and to await the results of the study to develop and trial a more accurate test than the prostate specific antigen test alone, to improve the balance of benefit and harm of screening.

25 Nov 2025·Department of Health and Social Care·Answered
Asked

What steps he is taking to improve support for women’s menopausal health, including (a) training for GPs and (b) training for prescribing nurses.

Reply

The Government is committed to prioritising women’s health, including menopause, as we reform the National Health Service, and women’s equality will be at the heart of our health missions.That is why menopause will be added to the NHS Health Checks from 2026 for eligible women aged 40 to 55 years old who attend. This will support up to five million eligible women across England to access high quality information on menopause, including advice on managing symptoms and where to seek support.For new doctors starting their careers in the United Kingdom, the General Medical Council has introduced the Medical Licensing Assessment to encourage a better understanding of common women’s health problems. The content for this assessment includes several topics relating to women’s health, including menopause, and will encourage a better understanding of common women’s health problems.Additionally, for general practitioners and other primary healthcare professionals, the Royal College of General Practitioners (RCGP) has published a Women’s Health Library which brings together educational resources and guidelines on women’s health, including menopause, from the RCGP, the Royal College of Obstetricians and Gynaecologists, and the College of Sexual and Reproductive Healthcare.The National Institute for Health and Care Excellence has also developed a women’s and reproductive health topic suite, and updated guidelines on menopause in November 2024. The guideline recommends more treatment choices for menopause symptoms, and prescribers are encouraged to use these guidelines as best practice when making decisions relating to menopause.

25 Nov 2025·Department of Health and Social Care·Answered
Asked

With reference to the planned inclusion of menopause in women’s health checks from 2026, what preparations his Department is making for that change.

Reply

We will be working with experts, including general practitioners, over the coming months to design the menopause content for the NHS Health Check.The NHS Health Check Best Practice Guidance will be updated to reflect the addition of menopause, and it will be for local authority commissioners to implement this through their NHS Health Check providers and to ensure that staff have adequate training. This will support eligible women to access high quality information on the menopause including advice on managing symptoms and where to seek support plus treatment options.

18 Nov 2025·Department of Health and Social Care·Answered
Asked

What assessment he has made of the potential impact of permanently removing in-patient beds from the Ellen Badger Hospital in Shipston on Stour on acute hospital discharges.

Reply

This is a matter for the Coventry and Warwickshire Integrated Care Board (ICB). That is because it is for ICBs to consider, working in partnership with local National Health Service providers and adult social care services, the right configuration of capacity locally to minimise delayed discharges from acute hospitals. In doing so, ICBs must consider the interests of their whole population and value for the taxpayer.

17 Nov 2025·Department of Health and Social Care·Answered
Asked

What steps he is taking to ensure that children with ADHD and autism who are assessed and treated privately as a result of long NHS waiting times are able to access shared care prescribing arrangements through their NHS GP pursuant to section 42 of the Children and Families Act 2014.

Reply

It is the responsibility of the integrated care boards in England to make available appropriate provision to meet the health and care needs of their local population, including providing access to attention deficit hyperactivity disorder and autism assessment and support services, in line with relevant National Institute for Health and Care Excellence guidelines.Shared care with the National Health Service refers to an arrangement whereby a specialist doctor formally transfers responsibility for all or some aspects of their patient’s care, such as the prescription of medication, over to the patient’s general practitioner (GP).The General Medical Council (GMC), which regulates and sets standards for doctors in the United Kingdom, has made it clear that GPs cannot be compelled to enter into a shared care agreement. GPs may decline such requests on clinical or capacity grounds.The GMC has issued guidance on prescribing and managing medicines, which helps GPs decide whether to accept shared care responsibilities. In deciding whether to enter into a shared care agreement, a GP will need to consider a number of factors such as whether the proposed activity is within their sphere of competence, and therefore safe and suitable for their patient’s needs. This includes the GP being satisfied that any prescriptions or referrals for treatment are clinically appropriate.If a shared care arrangement cannot be put in place after the treatment has been initiated, the responsibility for continued prescribing falls upon the specialist clinician, and this applies to both NHS and private medical care.

17 Nov 2025·Department of Health and Social Care·Answered
Asked

Whether his Department has made an assessment of compliance by GP practices with their obligations under (a) NICE guideline NG87, (b) the Equality Act 2010 and (c) section 42 of the Children and Families Act 2014 in relation to children with ADHD or autism.

Reply

The National Institute for Health and Care Excellence (NICE) is an independent body and part of their responsibility is for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources.NICE guidelines provide recommendations on best practice in terms of both the effectiveness and cost-effectiveness of interventions and services. Although not mandatory, guidelines describe best practice and NHS organisations are expected to take them fully into account in designing services to meet the needs of their local populations.In terms of the guidance NG87, which is on the diagnosis and management of attention deficit hyperactivity disorder (ADHD), the NICE guideline does not recommend a maximum waiting time for people to receive an assessment for ADHD or a diagnosis, although it does set out best practice on providing a diagnosis. As stated in the Medium Term Planning Framework, all integrated care boards and providers must optimise existing resources to reduce long waits for autism and ADHD assessments and improve the quality of assessments by implementing existing and new guidance, as published, including NICE guidelines. The Medium Term Planning Framework is available at the following link:https://www.england.nhs.uk/wp-content/uploads/2025/10/medium-term-planning-framework-delivering-change-together-2026-27-to-2028-29.pdfUnder the Equality Act 2010, health and social care organisations must make reasonable adjustments to ensure that people with disabilities are not disadvantaged. To make it easier for everyone to use health services, NHS England published guidance for NHS commissioners and providers in July 2025. Further information is available at the following link:https://www.england.nhs.uk/long-read/health-inequalities-equality-legal-duties/NHS England is rolling out the Reasonable Adjustments Digital Flag, which helps healthcare and social care providers identify and implement necessary adjustments for disabled people including autistic people and people with ADHD. This tool support care teams to be aware of individual needs, facilitating appropriate care.On the duty to secure special education provision and health care provision in accordance with education, health and care plans, if the plan specifies health care provision, the responsible commissioning body must arrange the specified health care provision for the child or young person. According to the Children and Families Act 2024 section 42, an education, health and care plan will specify the health care provision, the responsible commissioning body, referred to as the integrated care board, and must arrange the specified health care provision for the child or young person.

17 Nov 2025·Department of Health and Social Care·Answered
Asked

What assessment his Department has made of the potential impact of limited access to affordable fresh food on health inequalities in rural areas.

Reply

The Government’s Eatwell Guide advises that people should eat plenty of fruit and vegetables, and wholegrain or higher-fibre foods, as well as less processed meat, and food and drink that is high in sugar, calories, saturated fat, and salt. This includes at least five portions of a variety of fruits and vegetables every day. Fresh, frozen, tinned, and dried fruit and vegetables all count. The Eatwell Guide indicates that many foods classified as ‘ultra processed’ such as crisps, biscuits, cakes, confectionery, and ice cream are not part of a healthy, balanced diet.The Department of Health and Social Care (DHSC) and the Department for Environment, Food and Rural Affairs (DEFRA), alongside other Government departments, are funding research on a number of food system trials through the SALIENT programme. The programme prioritises interventions and partners that have the largest reach and the greatest potential to narrow health inequalities, both geographic and socio-economic. These trials include research on food and vegetable pricing in supermarkets and evaluating the effect of food pantries on food insecurity. DEFRA’s 2024 report on food insecurity also considered inequalities in access to a healthy, sustainable diet.DHSC is working closely with DEFRA to develop their cross-Government Food Strategy, which aims to improve affordability and access to healthier food, to help both adults and children live longer, healthier lives. We are committed to making the healthier choice the easier choice.Earlier this year, the Government committed to reviewing the School Food Standards to reflect the most recent Government dietary recommendations. Free school meals will also be extended to all children from households in receipt of Universal Credit from September 2026, including in rural areas. Our free breakfast clubs started with 750 early adopter schools in April 2025, and we have just announced the next wave of 500 schools, with 40% of pupils on free school meals to benefit from the programme from April 2026. The aim of these programmes is to ensure children receive nutritious meals at school and to remove barriers to opportunity.Our Healthy Food Schemes, which comprises of Healthy Start, the School Fruit and Veg Scheme, and the Nursery Milk Scheme, provides support for those who need it the most to eat a healthy, balanced diet. Healthy Start provides funding to pregnant women, babies, and young children under four years old from very low-income households to support a healthier diet. In April 2026, the value of weekly payments will increase by 10%.DHSC is working at pace to develop proposals set out in our 10-Year Health Plan commitments, to introduce mandatory healthier sales reporting for large food businesses and then set new targets to increase the healthiness of sales.We will work closely with business to implement these commitments, and plan to conduct extensive engagement with industry and wider stakeholders throughout policy development. To assist us in the development of the mandatory reporting we will commence our formal engagement with businesses shortly. This will involve a series of workshops with a cross-sector industry working group.

17 Nov 2025·Department of Health and Social Care·Answered
Asked

How many NHS GP practices in (a) England, (b) Coventry & Warwickshire, and (c) Stratford-on-Avon have declined to enter into shared care arrangements for ADHD medication prescribed by private providers in each integrated care board area in the most recent 12-month period for which data is available.

Reply

The data requested is not held centrally. The Coventry and Warwickshire Integrated Care Board has also confirmed that it does not hold the relevant data. The General Medical Council (GMC), which regulates and sets standards for doctors in the United Kingdom, has issued guidance on prescribing and managing medicines, which helps general practitioners (GPs) decide whether to accept shared care responsibilities. In deciding whether to enter into a shared care agreement, a GP will need to consider a number of factors such as whether the proposed activity is within their sphere of competence, and therefore safe and suitable for their patient’s needs. This includes the GP being satisfied that any prescriptions or referrals for treatment are clinically appropriate.The GMC has made it clear that GPs cannot be compelled to enter into a shared care agreement. GPs may decline such requests on clinical or capacity grounds. If a shared care arrangement cannot be put in place after the treatment has been initiated, the responsibility for continued prescribing falls upon the specialist clinician, which applies to both National Health Service and private medical care.

← PreviousPage 3 of 7Next →
Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.